Yes, I asked him about this exact topic and brought it up as a concern. My understanding from him was that the FDA was the one who pushed for LL to be used alone I assume to determine the various MOA’s and then an ICI could be used at the end of the 12 month study if PDL-1 levels were elevated- And if it were deemed appropriate.